GT Biopharma (OXI) Q3 2018 Earnings Report

0 Followers

DE:OXI Upcoming Earnings

GT Biopharma's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q3 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:OXI earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 31, 2027	2026 (Q4)	―-	-2.01	―	―
Nov 11, 2026	2026 (Q3)	-2.27-	-18.82	―
Aug 14, 2026	2026 (Q2)	-1.81-2.72	-12.47	78.18% (+9.75)
May 18, 2026	2026 (Q1)	-0.10-0.10	-0.3	66.67% (+0.20)
Apr 01, 2026	2025 (Q4)	-4.99-50.35	-37.87	-32.93% (-12.47)
Nov 04, 2025	2025 (Q3)	-0.34-0.75	-1.39	45.75% (+0.64)
Aug 14, 2025	2025 (Q2)	-15.42-12.47	-49.21	74.65% (+36.74)
May 19, 2025	2025 (Q1)	-0.30-0.30	-1.49	79.88% (+1.19)
Feb 21, 2025	2024 (Q4)	-35.15-37.87	-1.95	-1846.39% (-35.93)
Nov 14, 2024	2024 (Q3)	―-34.70	-40.82	15.00% (+6.12)
Aug 14, 2024	2024 (Q2)	―-49.21	-37.43	-31.47% (-11.78)
May 15, 2024	2024 (Q1)	―-37.19	-6.8	-446.67% (-30.39)
Mar 26, 2024	2023 (Q4)	-61.23-48.65	-122.47	60.27% (+73.81)
Nov 01, 2023	2023 (Q3)	-57.83-40.82	-149.68	72.73% (+108.86)
Aug 07, 2023	2023 (Q2)	-68.04-37.43	-68.04	44.98% (+30.60)
May 15, 2023	2023 (Q1)	-98.65-6.80	-115.66	94.12% (+108.86)
Mar 30, 2023	2022 (Q4)	-119.06-122.47	-384.4	68.14% (+261.94)
Oct 31, 2022	2022 (Q3)	-74.84-149.68	-133.23	-12.35% (-16.45)
Aug 11, 2022	2022 (Q2)	-4.76-2.72	-4.08	33.33% (+1.36)
May 16, 2022	2022 (Q1)	-8.44-4.63	-49.8	90.71% (+45.18)
Mar 28, 2022	2021 (Q4)	-5.35-15.38	-45.04	65.86% (+29.66)
Nov 10, 2021	2021 (Q3)	-4.26-5.33	-17.34	69.27% (+12.01)
May 17, 2021	2020 (Q4)	―-49.80	-11.27	-341.71% (-38.53)
May 17, 2021	2021 (Q1)	―-	-11.27	―
Nov 15, 2018	2018 (Q3)	―-72.48	-127.08	42.96% (+54.60)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed